Patent · US Expired

Suppression of nuclear factor-κB dependent processes using oligonucleotides

US7268121B2 · kind B2 · utility

0Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 24, 2002
Grant dateSep 11, 2007
Priority date—
Expiry dateSep 6, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/341
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antisense oligonucleotides which hybridize with nuclear factor-κB(NF-κB) mRNA and methods of using these oligonucleotides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.